Arase N, Arase H, Takayanagi T, Mishima M, Iwabuchi K, Ogasawara K, Onoé K
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Immunobiology. 1995 Aug;193(5):378-90. doi: 10.1016/S0171-2985(11)80425-0.
T cell subsets that produce minor lymphocyte stimulatory (Mls) antigens were analyzed using mixed lymphocyte reaction (MLR) in vitro or clonal elimination assay in vivo. When lymph node T cells from B10.BR(Mls-1b) mice were stimulated with various T cell subsets from AKR (Mls-1a) mice in the presence of B10.BR antigen presenting cells (APC), proportions of Mls-1a reactive T cell blasts (V beta 6+, V beta 8.1+) increased. The stimulatory potency of CD8+ T cells was higher than that of CD4+ T cells. Furthermore, among either CD8+ or CD4+ T cell subset, CD44+ T cells appeared to produce larger amounts of Mls-1a antigens than CD44- T cells. More marked difference was demonstrated, when stimulator AKR T cells were being activated by immobilized anti-T cell antigen receptor (TCR) antibody during MLR. Thus, AKR T cells appeared to produce large amounts of Mls-1a antigens on appropriate stimulations. These findings were confirmed by the semiquantitative analysis of mRNA levels of MTV-7 in the AKR T cell subsets. When CD8+CD44+ T cells from (AKR x B10.BR)F1 mice were injected intravenously into [B10.BR-->B10.BR] syngeneic bone marrow (BM) chimeras 1 week after BM reconstitution and proportions of V beta 6+ T cells were quantitated 7 weeks later, significant clonal elimination of V beta 6+ T cells was induced among both thymocyte population and lymph node T cell population in a dose-dependent manner of the inoculated F1 T cells. Inoculation of CD8+CD44-F1 T cells eliminated V beta 6+ T cells less efficiently from lymph node T cells and inoculation of CD4+F1 T cells induced no significant clonal elimination of the V beta 6+ T cells. The present findings demonstrate clearly that CD8+CD44+ T cells represent the cells producing large amounts of Mls-1a antigens and inducing clonal elimination of V beta 6+ T cells in vivo.
利用体外混合淋巴细胞反应(MLR)或体内克隆清除试验,对产生次要淋巴细胞刺激(Mls)抗原的T细胞亚群进行了分析。当在B10.BR抗原呈递细胞(APC)存在的情况下,用来自AKR(Mls-1a)小鼠的各种T细胞亚群刺激来自B10.BR(Mls-1b)小鼠的淋巴结T细胞时,Mls-1a反应性T细胞母细胞(Vβ6 +,Vβ8.1 +)的比例增加。CD8 + T细胞的刺激效力高于CD4 + T细胞。此外,在CD8 +或CD4 + T细胞亚群中,CD44 + T细胞似乎比CD44 - T细胞产生更多的Mls-1a抗原。当在MLR期间用固定化抗T细胞抗原受体(TCR)抗体激活刺激物AKR T细胞时,差异更为明显。因此,AKR T细胞在适当刺激下似乎会产生大量的Mls-1a抗原。这些发现通过对AKR T细胞亚群中MTV-7 mRNA水平的半定量分析得到了证实。当在骨髓重建1周后,将来自(AKR×B10.BR)F1小鼠的CD8 + CD44 + T细胞静脉内注射到[B10.BR→B10.BR]同基因骨髓(BM)嵌合体中,并在7周后定量Vβ6 + T细胞的比例时,在胸腺细胞群体和淋巴结T细胞群体中均以接种的F1 T细胞的剂量依赖性方式诱导了Vβ6 + T细胞的显著克隆清除。接种CD8 + CD44 - F1 T细胞从淋巴结T细胞中清除Vβ6 + T细胞的效率较低,而接种CD4 + F1 T细胞未诱导Vβ6 + T细胞的显著克隆清除。目前的研究结果清楚地表明,CD8 + CD44 + T细胞代表在体内产生大量Mls-1a抗原并诱导Vβ6 + T细胞克隆清除的细胞。